About Stamm Biotech
Stamm Biotech is a company based in San Francisco (United States) founded in 2017.. Stamm Biotech has raised $17.25 million across 2 funding rounds from investors including GRIDX, Vista Equity Partners and Abundance Venture Capital. Stamm Biotech offers products and services including Bioprocessor, Bioengineering Solutions, and Bio AI Pipelines. Stamm Biotech operates in a competitive market with competitors including MaxCyte, SQZBiotech, Fluxion Biosciences, Berkeley Lights and LBT Innovations, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.25 M (USD)
in 2 rounds
-
Latest Funding Round
$17 M (USD), Series A
Mar 01, 2022
-
Investors
GRIDX
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stamm Biotech
Stamm Biotech offers a comprehensive portfolio of products and services, including Bioprocessor, Bioengineering Solutions, and Bio AI Pipelines. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated system for continuous biologics and cell therapies production.
End-to-end support for clinical and commercial manufacturing processes.
AI models for predicting cell behavior from multi-omics data.
Unlock access to complete
Funding Insights of Stamm Biotech
Stamm Biotech has successfully raised a total of $17.25M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $17 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $17.0M
-
First Round
First Round
(20 Sep 2018)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series A - Stamm Biotech | Valuation | Varana Capital | |
| Sep, 2018 | Amount | Seed - Stamm Biotech | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Stamm Biotech
Stamm Biotech has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include GRIDX, Vista Equity Partners and Abundance Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward high-growth enterprise software and technology companies.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital and accelerator services are provided across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Stamm Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Stamm Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Stamm Biotech Comparisons
Competitors of Stamm Biotech
Stamm Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MaxCyte, SQZBiotech, Fluxion Biosciences, Berkeley Lights and LBT Innovations, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for cell processing and modification are provided.
|
|
| domain | founded_year | HQ Location |
Cell therapies are developed using proprietary Cell Squeeze technology.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based tools for cellular analysis are provided.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based systems for single-cell isolation and analysis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of AI-based automated solutions for the preparation and analysis of microbiology culture specimens
|
|
| domain | founded_year | HQ Location |
Supplement reagents for cell and gene therapy are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Stamm Biotech
Frequently Asked Questions about Stamm Biotech
When was Stamm Biotech founded?
Stamm Biotech was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Stamm Biotech located?
Stamm Biotech is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Stamm Biotech a funded company?
Stamm Biotech is a funded company, having raised a total of $17.25M across 2 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Sep 20, 2018.
What does Stamm Biotech do?
Stamm Biotech was founded in 2017 and is based in San Francisco, United States. Operations focus on the biotechnology sector, where cell processing platforms are designed and developed as bioproduction systems. These platforms track biological, physical, and chemical variations within bioprocessors. Strain behavior in bioreactors is predicted through this monitoring, supporting applications in research and industrial settings.
Who are the top competitors of Stamm Biotech?
Stamm Biotech's top competitors include MaxCyte, SQZBiotech and Mytos.
What products or services does Stamm Biotech offer?
Stamm Biotech offers Bioprocessor, Bioengineering Solutions, and Bio AI Pipelines.
Who are Stamm Biotech's investors?
Stamm Biotech has 12 investors. Key investors include GRIDX, Vista Equity Partners, Abundance Venture Capital, Trillian, and Teramips Technologies.